Fluetizolam

This article will address Fluetizolam from a broad and deep perspective, with the aim of providing the reader with a complete and detailed vision of this topic. The importance of Fluetizolam in today's society is undeniable, so it is essential to delve into its meaning, origin, development and repercussions. Through an exhaustive and rigorous analysis, the aim is to shed light on the different aspects that revolve around Fluetizolam, providing relevant and updated information that allows us to understand its relevance today. Likewise, different points of view and opinions of experts on the subject will be explored, in order to enrich the debate and offer a plural and enriching vision about Fluetizolam.

Fluetizolam
Legal status
Legal status
Identifiers
  • 4-ethyl-7-(2-fluorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclotrideca-2(6),4,7,10,12-pentaene
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC17H15FN4S
Molar mass326.39 g·mol−1
3D model (JSmol)
  • CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4F)C
  • InChI=1S/C17H15FN4S/c1-3-11-8-13-16(12-6-4-5-7-14(12)18)19-9-15-21-20-10(2)22(15)17(13)23-11/h4-8H,3,9H2,1-2H3
  • Key:BCKPHENWWQCRCG-UHFFFAOYSA-N

Fluetizolam (2-ethyl-4-(2-fluorophenyl)-9-methyl-6H-thienotriazolodiazepine) is a thienotriazolodiazepine derivative with potent sedative and anxiolytic effects, which has been sold as a designer drug.

See also

References

  1. ^ EP 0776892, Kitajima H, Ehara S, Sato H, Moriwaki M, Onishi K, "Thienylazole compound and thienotriazolodiazepine compound.", issued 4 June 1997, assigned to Yoshitomi Pharmaceutical 
  2. ^ Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, et al. (July 2021). "The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". Pharmaceuticals (Basel, Switzerland). 14 (8): 720. doi:10.3390/ph14080720. PMC 8398354. PMID 34451817.